Norden Gregory, a director at Royalty Pharma plc ($RPRX), made one open market sale of common shares in the last 365 days, totaling $1.21 million. His most recent sale occurred on August 11, 2025. This places his sales volume in 4497th position among 11,678 individual insiders, where the average is $8.6 million across about 6.4 transactions. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Zoetis Inc. | $ZTS | Norden Gregory | Director | G | Common Stock | 1213 | $0.00 | 18,167.1922 | 443,835,000 | 6.26% | 0.00% |
| Feb. 19, 2026 | Zoetis Inc. | $ZTS | Norden Gregory | Director | J | Common Stock | 406 | $127.28 | 18,167.1922 | 443,835,000 | 2.19% | 0.00% |
| Feb. 19, 2026 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Common Stock | 1619 | $0.00 | 18,573.1922 | 443,835,000 | 9.55% | 0.00% |
| Feb. 19, 2026 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Restricted Stock Unit | 1619 | $0.00 | 1,936.0000 | 443,835,000 | 45.55% | 0.00% |
| Feb. 18, 2026 | Zoetis Inc. | $ZTS | Norden Gregory | Director | A | Restricted Stock Unit | 1936 | $0.00 | 3,555.3325 | 443,835,000 | 119.56% | 0.00% |
| Aug. 8, 2025 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | C | Class A Ordinary Shares | 144660 | $0.00 | 228,348.0000 | 594,108,000 | 172.86% | 0.02% |
| Aug. 11, 2025 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | S | Class A Ordinary Shares | 33500 | $36.23 | 194,848.0000 | 594,108,000 | 14.67% | 0.01% |
| Aug. 8, 2025 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | C | LP interests in RPI US Partners 2019, LP | 14466 | $0.00 | 0.0000 | 594,108,000 | 100.00% | 0.00% |
| June 26, 2025 | Praxis Precision Medicines, Inc. | $PRAX | Norden Gregory | Director | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 20,163,250 | 9999.99% | 0.05% |
| May 13, 2025 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | A | Class A Ordinary Shares | 7614 | $0.00 | 83,688.0000 | 594,108,000 | 10.01% | 0.00% |
| Feb. 19, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | A | Restricted Stock Unit | 1596 | $0.00 | 1,596.0000 | 454,848,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | G | Common Stock | 1843 | $0.00 | 16,954.1922 | 454,848,000 | 9.80% | 0.00% |
| Feb. 8, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | J | Common Stock | 308 | $171.43 | 16,954.1922 | 454,848,000 | 1.78% | 0.00% |
| Feb. 8, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Restricted Stock Unit | 1225 | $0.00 | 0.0000 | 454,848,000 | 100.00% | 0.00% |
| Feb. 8, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Common Stock | 1225 | $0.00 | 17,262.1922 | 454,848,000 | 7.64% | 0.00% |
| Feb. 6, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | J | Common Stock | 310 | $174.12 | 16,037.1922 | 454,848,000 | 1.90% | 0.00% |
| Feb. 6, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Restricted Stock Unit | 1236 | $0.00 | 1,225.4023 | 454,848,000 | 50.22% | 0.00% |
| Feb. 6, 2025 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Common Stock | 1236 | $0.00 | 16,347.1922 | 454,848,000 | 8.18% | 0.00% |
| June 7, 2024 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | A | Class A Ordinary Shares | 9293 | $0.00 | 73,738.0000 | 602,900,000 | 14.42% | 0.00% |
| June 5, 2024 | Praxis Precision Medicines, Inc. | $PRAX | Norden Gregory | Director | A | Stock Option (Right to Buy) | 8566 | $0.00 | 8,566.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | G | Common Stock | 2214 | $0.00 | 15,111.1922 | 462,269,000 | 12.78% | 0.00% |
| Feb. 10, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Common Stock | 1463 | $0.00 | 16,696.1922 | 462,269,000 | 9.60% | 0.00% |
| Feb. 10, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Restricted Stock Unit | 1463 | $0.00 | 2,435.3053 | 462,269,000 | 37.54% | 0.00% |
| Feb. 10, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | J | Common Stock | 367 | $197.32 | 16,329.1922 | 462,269,000 | 2.20% | 0.00% |
| Feb. 8, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Restricted Stock Unit | 1493 | $0.00 | 3,898.6990 | 462,269,000 | 27.69% | 0.00% |
| Feb. 8, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | J | Common Stock | 375 | $195.75 | 15,233.1922 | 462,269,000 | 2.40% | 0.00% |
| Feb. 8, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | M | Common Stock | 1493 | $0.00 | 15,608.1922 | 462,269,000 | 10.58% | 0.00% |
| Feb. 6, 2024 | Zoetis Inc. | $ZTS | Norden Gregory | Director | A | Restricted Stock Unit | 1223 | $0.00 | 5,391.9642 | 462,269,000 | 29.34% | 0.00% |
| June 23, 2023 | Royalty Pharma plc | $RPRX | Norden Gregory | Director | A | Class A Ordinary Shares | 7747 | $0.00 | 64,445.0000 | 437,972,000 | 13.66% | 0.00% |
| June 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | Norden Gregory | Director | A | Stock Option (Right to Buy) | 28981 | $0.00 | 28,981.0000 | 0 | 9999.99% | 0.00% |